CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.79B, above the global median of $1.18B
- FinancialsAltman Z-Score 3.67: safe zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.15%
Annual Rate
INR 14.42Paid unknown
Payout Ratio
15.4%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
171.52BINR1.79B · vs all stocks (USD)
Trailing P/E
26.86xRevenue (TTM)
32.12BINR334.76M · vs all stocks (USD)
Profit Margin
20.04%Beta
-0.0480xvs all stocks
52-Week Change
-23.90%vs all stocks
Forward Annual Dividend Yield
1.15%vs all stocks
Market Capitalization
171.52BINR1.79B · vs all stocks (USD)
Enterprise Value
197.22BINR2.06B · vs all stocks (USD)
Trailing P/E
26.86xForward P/E
21.74xPEG Ratio
1.44xPrice to Sales (TTM)
5.43xPrice to Book (MRQ)
4.41xEnterprise to Revenue
6.14xEnterprise to EBITDA
17.41xGross Margin
72.47%Profit Margin
20.04%Operating Margin
25.79%Return on Assets (TTM)
8.41%Return on Equity (TTM)
15.90%Revenue (TTM)
32.12BINR334.76M · vs all stocks (USD)
Revenue per Share (TTM)
234.08INRUpdated Sep 29, 2026Quarterly Revenue Growth
12.60%Gross Profit (TTM)
23.62BINR246.16M · vs all stocks (USD)
EBITDA (TTM)
11.46BINR119.41M · vs all stocks (USD)
Net Income (TTM)
6.44BINR67.10M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
20.70%Operating Cash Flow (TTM)
5.38BINR56.06M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
6.20BINR64.56M · vs all stocks (USD)
Forward Annual Dividend Rate
14.42INRUpdated Sep 29, 2026Forward Annual Dividend Yield
1.15%vs all stocks
Trailing Annual Dividend Rate
0.00INRUpdated Sep 29, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
15.38%Minority Interest (Equity)
-70.10MINRFY2026 · Mar 31, 2026Revenue
31.15BINRFY2026 · Mar 31, 2026Cost of Goods Sold
7.96BINRFY2026 · Mar 31, 2026Gross Profit
23.19BINRFY2026 · Mar 31, 2026Operating Income
8.41BINR87.60M · vs all stocks (USD)
Pre-tax Income
6.39BINRFY2026 · Mar 31, 2026Income Tax Expense
-89.70MINRFY2026 · Mar 31, 2026Net Income
6.48BINRFY2026 · Mar 31, 2026EBIT
8.31BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
11.28BINRFY2026 · Mar 31, 2026Other Operating Expenses
6.57BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
1.93BINRFY2026 · Mar 31, 2026EPS (Basic)
45.33INRFY2026 · Mar 31, 2026EPS (Diluted)
45.26INRFY2026 · Mar 31, 2026Basic Shares Outstanding
136.66MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
136.66MSharesFY2026 · Mar 31, 2026Minority Interests (P&L)
-279.90MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
4.37BINRFY2026 · Mar 31, 2026Free Cash Flow
1.41BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
547.40MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
6.39BINRFY2026 · Mar 31, 2026Stock-based Compensation
80.00MINRFY2026 · Mar 31, 2026Other Non-cash Items
2.06BINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-2.10BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-2.05BINRFY2026 · Mar 31, 2026Capital Expenditures
-2.97BINRFY2026 · Mar 31, 2026Net Acquisitions
-100.00MINRFY2026 · Mar 31, 2026Purchase of Investments
-346.50MINRFY2026 · Mar 31, 2026Sale of Investments
167.50MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-3.25BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
1.17BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-2.82BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
530.00MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-1.07BINRFY2026 · Mar 31, 2026Shares Outstanding
138.74MSharesUpdated Sep 29, 2026Float Shares
44.18MSharesUpdated Sep 29, 2026% Held by Insiders
69.84%vs all stocks
% Held by Institutions
22.33%vs all stocks
Total Cash (MRQ)
673.00MINR7.01M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.86INRUpdated Sep 29, 2026Total Debt (MRQ)
23.59BINR245.79M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6055xCurrent Ratio (MRQ)
0.7413xBook Value per Share (MRQ)
285.48INRUpdated Sep 29, 2026Total Assets
73.66BINR767.56M · vs all stocks (USD)
Total Current Assets
15.40BINRFY2026 · Mar 31, 2026Total Liabilities
34.70BINRFY2026 · Mar 31, 2026Total Non-current Assets
58.26BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
13.93BINRFY2026 · Mar 31, 2026Total Current Liabilities
20.77BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
547.40MINRFY2026 · Mar 31, 2026Other Short-term Investments
216.40MINRFY2026 · Mar 31, 2026Accounts Receivable
6.80BINRFY2026 · Mar 31, 2026Inventory
4.37BINRFY2026 · Mar 31, 2026Accounts Payable
3.30BINRFY2026 · Mar 31, 2026Short-term Debt
13.63BINRFY2026 · Mar 31, 2026Other Current Liabilities
716.40MINRFY2026 · Mar 31, 2026Long-term Debt
9.96BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
38.00MINRFY2026 · Mar 31, 2026Common Stock (Book)
138.50MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
38.96BINR405.97M · vs all stocks (USD)
52-Week Low
1.20KINRUpdated Sep 29, 202652-Week High
1.74KINRUpdated Sep 29, 202652-Week Change
-23.90%vs all stocks
Beta
-0.0480xvs all stocks
50-Day MA
1.35KINRUpdated Sep 29, 2026200-Day MA
1.39KINRUpdated Sep 29, 2026Avg 10-Day Volume
48.14KSharesUpdated Sep 29, 2026Avg 30-Day Volume
60.00KSharesUpdated Sep 29, 2026Diluted EPS (TTM)
46.83INRUpdated Sep 29, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.67: safe zoneNotable
Altman Z-Score: 3.67
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.79B, above the global median of $1.18BNotable
Market cap (USD): 1,787,435,970.322Global Median: 1,180,223,658.953
Levered free cash flow is $64.56M, above the global median of $18.73MNotable
Levered free cash flow (USD): 64,560,179.2Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Jafron Biomedical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xeris Biopharma Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zenas BioPharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Vir Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
PolyPeptide Group AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
Alivus Life Sciences Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cohance Lifesciences Limited
Tier 1ProductionApproval-Gated PipelineRule
4DMedical Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Septarna Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Max Healthcare Institute Ltd.
5 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetReceivables Heavy and GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book Value
Rategain Travel Technologies Ltd.
4 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetReceivables Heavy and GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income Growth
Fortis Healthcare Ltd.
4 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetReceivables Heavy and GrowingMulti-Year Revenue, Profit, And Income GrowthPrice Below Mean With Profitability And Book Value